Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 260

1.

Coexisting renal artery stenosis and metabolic syndrome magnifies mitochondrial damage, aggravating poststenotic kidney injury in pigs.

Nargesi AA, Zhang L, Tang H, Jordan KL, Saadiq IM, Textor SC, Lerman LO, Eirin A.

J Hypertens. 2019 Oct;37(10):2061-2073. doi: 10.1097/HJH.0000000000002129.

PMID:
31465309
2.

Senescent Kidney Cells in Hypertensive Patients Release Urinary Extracellular Vesicles.

Santelli A, Sun IO, Eirin A, Abumoawad AM, Woollard JR, Lerman A, Textor SC, Puranik AS, Lerman LO.

J Am Heart Assoc. 2019 Jun 4;8(11):e012584. doi: 10.1161/JAHA.119.012584. Epub 2019 Jun 1.

3.

A modified two-compartment model for measurement of renal function using dynamic contrast-enhanced computed tomography.

Jiang K, Ferguson CM, Abumoawad A, Saad A, Textor SC, Lerman LO.

PLoS One. 2019 Jul 10;14(7):e0219605. doi: 10.1371/journal.pone.0219605. eCollection 2019.

4.

Novel therapeutic strategies for renovascular disease.

Eirin A, Textor SC, Lerman LO.

Curr Opin Nephrol Hypertens. 2019 Jul;28(4):383-389. doi: 10.1097/MNH.0000000000000513.

PMID:
31045658
5.

Early podocyte injury and elevated levels of urinary podocyte-derived extracellular vesicles in swine with metabolic syndrome: role of podocyte mitochondria.

Zhang LH, Zhu XY, Eirin A, Nargesi AA, Woollard JR, Santelli A, Sun IO, Textor SC, Lerman LO.

Am J Physiol Renal Physiol. 2019 Jul 1;317(7):F12-F22. doi: 10.1152/ajprenal.00399.2018. Epub 2019 May 1.

PMID:
31042059
6.

Tissue hypoxia, inflammation, and loss of glomerular filtration rate in human atherosclerotic renovascular disease.

Abumoawad A, Saad A, Ferguson CM, Eirin A, Woollard JR, Herrmann SM, Hickson LJ, Bendel EC, Misra S, Glockner J, Lerman LO, Textor SC.

Kidney Int. 2019 Apr;95(4):948-957. doi: 10.1016/j.kint.2018.11.039.

PMID:
30904069
7.

Impact of Serum Uric Acid Levels on Outcomes following Renal Artery Revascularization in Patients with Renovascular Disease.

Chen XJ, Eirin A, Kane GC, Misra S, Textor SC, Lerman A, Lerman LO.

Int J Hypertens. 2019 Jan 30;2019:3872065. doi: 10.1155/2019/3872065. eCollection 2019.

8.

Urinary mitochondrial DNA copy number identifies renal mitochondrial injury in renovascular hypertensive patients undergoing renal revascularization: A Pilot Study.

Eirin A, Herrmann SM, Saad A, Abumoawad A, Tang H, Lerman A, Textor SC, Lerman LO.

Acta Physiol (Oxf). 2019 Jul;226(3):e13267. doi: 10.1111/apha.13267. Epub 2019 Mar 13.

PMID:
30803138
9.

Renal Adiposity Does not Preclude Quantitative Assessment of Renal Function Using Dual-Energy Multidetector CT in Mildly Obese Human Subjects.

Ferguson CM, Eirin A, Michalak GJ, Hedayat AF, Abumoawad AM, Saad A, Zhu X, Textor SC, McCollough CH, Lerman LO.

Acad Radiol. 2019 Jan 14. pii: S1076-6332(19)30001-7. doi: 10.1016/j.acra.2018.12.008. [Epub ahead of print]

10.

Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.

Carey RM, Calhoun DA, Bakris GL, Brook RD, Daugherty SL, Dennison-Himmelfarb CR, Egan BM, Flack JM, Gidding SS, Judd E, Lackland DT, Laffer CL, Newton-Cheh C, Smith SM, Taler SJ, Textor SC, Turan TN, White WB; American Heart Association Professional/Public Education and Publications Committee of the Council on Hypertension; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Genomic and Precision Medicine; Council on Peripheral Vascular Disease; Council on Quality of Care and Outcomes Research; and Stroke Council.

Hypertension. 2018 Nov;72(5):e53-e90. doi: 10.1161/HYP.0000000000000084.

11.

Emerging Paradigms in Chronic Kidney Ischemia.

Eirin A, Textor SC, Lerman LO.

Hypertension. 2018 Nov;72(5):1023-1030. doi: 10.1161/HYPERTENSIONAHA.118.11082. Review. No abstract available.

PMID:
30354824
12.

Loss of Renal Peritubular Capillaries in Hypertensive Patients Is Detectable by Urinary Endothelial Microparticle Levels.

Sun IO, Santelli A, Abumoawad A, Eirin A, Ferguson CM, Woollard JR, Lerman A, Textor SC, Puranik AS, Lerman LO.

Hypertension. 2018 Nov;72(5):1180-1188. doi: 10.1161/HYPERTENSIONAHA.118.11766.

PMID:
30354805
13.

Kidney-resident macrophages promote a proangiogenic environment in the normal and chronically ischemic mouse kidney.

Puranik AS, Leaf IA, Jensen MA, Hedayat AF, Saad A, Kim KW, Saadalla AM, Woollard JR, Kashyap S, Textor SC, Grande JP, Lerman A, Simari RD, Randolph GJ, Duffield JS, Lerman LO.

Sci Rep. 2018 Sep 17;8(1):13948. doi: 10.1038/s41598-018-31887-4.

14.

Emerging evidence on renal denervation for the treatment of hypertension.

Wyatt CM, Textor SC.

Kidney Int. 2018 Oct;94(4):644-646. doi: 10.1016/j.kint.2018.08.002. Epub 2018 Aug 26. No abstract available.

PMID:
30158056
15.

Impact of aortic wall thrombus on late changes in renal function among patients treated by fenestrated-branched endografts.

Sandri GA, Oderich GS, Tenorio ER, Ribeiro MS, Reis de Souza L, Cha SS, Macedo TA, Textor SC.

J Vasc Surg. 2019 Mar;69(3):651-660.e4. doi: 10.1016/j.jvs.2018.05.243. Epub 2018 Aug 25.

PMID:
30154012
16.

Renal blood oxygenation level-dependent magnetic resonance imaging to measure renal tissue oxygenation: a statement paper and systematic review.

Pruijm M, Mendichovszky IA, Liss P, Van der Niepen P, Textor SC, Lerman LO, Krediet CTP, Caroli A, Burnier M, Prasad PV.

Nephrol Dial Transplant. 2018 Sep 1;33(suppl_2):ii22-ii28. doi: 10.1093/ndt/gfy243.

17.

Mitoprotection preserves the renal vasculature in porcine metabolic syndrome.

Eirin A, Hedayat AF, Ferguson CM, Textor SC, Lerman A, Lerman LO.

Exp Physiol. 2018 Jul;103(7):1020-1029. doi: 10.1113/EP086988. Epub 2018 May 27.

18.

Total Renal Artery Occlusion: Recovery of Function After Revascularization.

Manohar S, Hamadah A, Herrmann SM, Textor SC.

Am J Kidney Dis. 2018 May;71(5):748-753. doi: 10.1053/j.ajkd.2017.11.014. Epub 2018 Feb 9. Review.

19.

Intrarenal fat deposition does not interfere with the measurement of single-kidney perfusion in obese swine using multi-detector computed tomography.

Ferguson CM, Eirin A, Michalak GJ, Hedayat AF, Abumoawad A, Saad A, Zhu X, Textor SC, McCollough CH, Lerman LO.

J Cardiovasc Comput Tomogr. 2018 Mar - Apr;12(2):149-152. doi: 10.1016/j.jcct.2018.01.003. Epub 2018 Jan 10.

20.

Current Concepts in the Treatment of Renovascular Hypertension.

Herrmann SM, Textor SC.

Am J Hypertens. 2018 Jan 12;31(2):139-149. doi: 10.1093/ajh/hpx154.

21.

Phase 2a Clinical Trial of Mitochondrial Protection (Elamipretide) During Stent Revascularization in Patients With Atherosclerotic Renal Artery Stenosis.

Saad A, Herrmann SMS, Eirin A, Ferguson CM, Glockner JF, Bjarnason H, McKusick MA, Misra S, Lerman LO, Textor SC.

Circ Cardiovasc Interv. 2017 Sep;10(9). pii: e005487. doi: 10.1161/CIRCINTERVENTIONS.117.005487.

22.

BP Targets in CKD, Mortality, and SPRINT: What Have We Learned?

Textor SC, Schwartz GL.

J Am Soc Nephrol. 2017 Sep;28(9):2561-2563. doi: 10.1681/ASN.2017060652. Epub 2017 Jul 20. No abstract available.

23.

Glomerular Hyperfiltration in Obese African American Hypertensive Patients Is Associated With Elevated Urinary Mitochondrial-DNA Copy Number.

Eirin A, Saad A, Woollard JR, Juncos LA, Calhoun DA, Tang H, Lerman A, Textor SC, Lerman LO.

Am J Hypertens. 2017 Nov 1;30(11):1112-1119. doi: 10.1093/ajh/hpx103. Erratum in: Am J Hypertens. 2017 Nov 1;30(11):1145.

24.

Renal Adiposity Confounds Quantitative Assessment of Markers of Renal Diffusion With MRI: A Proposed Correction Method.

Ebrahimi B, Saad A, Jiang K, Ferguson CM, Tang H, Woollard JR, Glockner JF, Textor SC, Lerman LO.

Invest Radiol. 2017 Nov;52(11):672-679. doi: 10.1097/RLI.0000000000000389.

25.

Evidence and Renovascular Disease: Trials and Mistrials?

Textor SC, Herrmann SM.

Am J Kidney Dis. 2017 Aug;70(2):160-163. doi: 10.1053/j.ajkd.2017.04.013. Epub 2017 May 20. No abstract available.

26.

Autologous Mesenchymal Stem Cells Increase Cortical Perfusion in Renovascular Disease.

Saad A, Dietz AB, Herrmann SMS, Hickson LJ, Glockner JF, McKusick MA, Misra S, Bjarnason H, Armstrong AS, Gastineau DA, Lerman LO, Textor SC.

J Am Soc Nephrol. 2017 Sep;28(9):2777-2785. doi: 10.1681/ASN.2017020151. Epub 2017 May 1.

27.

Preserved endothelial progenitor cell angiogenic activity in African American essential hypertensive patients.

Kim SR, Eirin A, Herrmann SMS, Saad A, Juncos LA, Lerman A, Textor SC, Lerman LO.

Nephrol Dial Transplant. 2018 Mar 1;33(3):392-401. doi: 10.1093/ndt/gfx032.

28.

The metabolic syndrome induces early changes in the swine renal medullary mitochondria.

Eirin A, Woollard JR, Ferguson CM, Jordan KL, Tang H, Textor SC, Lerman A, Lerman LO.

Transl Res. 2017 Jun;184:45-56.e9. doi: 10.1016/j.trsl.2017.03.002. Epub 2017 Mar 11.

29.

Editor's Choice - Comparison of Renal Outcomes in Patients Treated by Zenith® Fenestrated and Zenith® Abdominal Aortic Aneurysm Stent grafts in US Prospective Pivotal Trials.

de Souza LR, Oderich GS, Farber MA, Haulon S, Banga PV, Pereira AH, Gloviczki P, Textor SC, Jia F; Zenith Fenestrated and the Zenith Infrarenal Stent grafts Trial Investigators.

Eur J Vasc Endovasc Surg. 2017 May;53(5):648-655. doi: 10.1016/j.ejvs.2017.02.005. Epub 2017 Mar 10.

30.

Renal Arterial Disease and Hypertension.

Textor SC.

Med Clin North Am. 2017 Jan;101(1):65-79. doi: 10.1016/j.mcna.2016.08.010. Review.

31.

Atherosclerotic renal artery stenosis is associated with elevated cell cycle arrest markers related to reduced renal blood flow and postcontrast hypoxia.

Saad A, Wang W, Herrmann SM, Glockner JF, Mckusick MA, Misra S, Bjarnason H, Lerman LO, Textor SC.

Nephrol Dial Transplant. 2016 Nov;31(11):1855-1863. Epub 2016 Jul 29.

32.

Relationship of Albuminuria and Renal Artery Stent Outcomes: Results From the CORAL Randomized Clinical Trial (Cardiovascular Outcomes With Renal Artery Lesions).

Murphy TP, Cooper CJ, Pencina KM, D'Agostino R, Massaro J, Cutlip DE, Jamerson K, Matsumoto AH, Henrich W, Shapiro JI, Tuttle KR, Cohen DJ, Steffes M, Gao Q, Metzger DC, Abernethy WB, Textor SC, Briguglio J, Hirsch AT, Tobe S, Dworkin LD.

Hypertension. 2016 Nov;68(5):1145-1152. Epub 2016 Sep 19.

33.

Development of renal atrophy in murine 2 kidney 1 clip hypertension is strain independent.

Kashyap S, Boyilla R, Zaia PJ, Ghossan R, Nath KA, Textor SC, Lerman LO, Grande JP.

Res Vet Sci. 2016 Aug;107:171-177. doi: 10.1016/j.rvsc.2016.06.002. Epub 2016 Jun 8.

34.

Emerging concepts for patients with treatment-resistant hypertension.

Eirin A, Textor SC, Lerman LO.

Trends Cardiovasc Med. 2016 Nov;26(8):700-706. doi: 10.1016/j.tcm.2016.05.004. Epub 2016 May 17. Review.

35.

Urinary Mitochondrial DNA Copy Number Identifies Chronic Renal Injury in Hypertensive Patients.

Eirin A, Saad A, Tang H, Herrmann SM, Woollard JR, Lerman A, Textor SC, Lerman LO.

Hypertension. 2016 Aug;68(2):401-10. doi: 10.1161/HYPERTENSIONAHA.116.07849. Epub 2016 Jun 20.

36.

Low-Energy Shockwave Therapy Improves Ischemic Kidney Microcirculation.

Zhang X, Krier JD, Amador Carrascal C, Greenleaf JF, Ebrahimi B, Hedayat AF, Textor SC, Lerman A, Lerman LO.

J Am Soc Nephrol. 2016 Dec;27(12):3715-3724. Epub 2016 Jun 13.

37.

Mortality and Renal Replacement Therapy after Renal Artery Stent Placement for Atherosclerotic Renovascular Disease.

Misra S, Khosla A, Allred J, Harmsen WS, Textor SC, McKusick MA.

J Vasc Interv Radiol. 2016 Aug;27(8):1215-24. doi: 10.1016/j.jvir.2016.05.001. Epub 2016 Jun 11.

38.

Restoration of Mitochondrial Cardiolipin Attenuates Cardiac Damage in Swine Renovascular Hypertension.

Eirin A, Ebrahimi B, Kwon SH, Fiala JA, Williams BJ, Woollard JR, He Q, Gupta RC, Sabbah HN, Prakash YS, Textor SC, Lerman A, Lerman LO.

J Am Heart Assoc. 2016 May 31;5(6). pii: e003118. doi: 10.1161/JAHA.115.003118.

39.

Does Renal Artery Stenting Prevent Clinical Events?

Textor SC, Misra S.

Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1125-7. doi: 10.2215/CJN.04640416. Epub 2016 May 25. No abstract available.

40.

Elevated urinary podocyte-derived extracellular microvesicles in renovascular hypertensive patients.

Kwon SH, Woollard JR, Saad A, Garovic VD, Zand L, Jordan KL, Textor SC, Lerman LO.

Nephrol Dial Transplant. 2017 May 1;32(5):800-807. doi: 10.1093/ndt/gfw077.

41.

Differential Expression of microRNAs in Urinary Extracellular Vesicles Obtained From Hypertensive Patients.

Kwon SH, Tang H, Saad A, Woollard JR, Lerman A, Textor SC, Lerman LO.

Am J Kidney Dis. 2016 Aug;68(2):331-332. doi: 10.1053/j.ajkd.2016.01.027. Epub 2016 Mar 16. No abstract available.

42.

Changes in inflammatory biomarkers after renal revascularization in atherosclerotic renal artery stenosis.

Wang W, Saad A, Herrmann SM, Eirin Massat A, McKusick MA, Misra S, Lerman LO, Textor SC.

Nephrol Dial Transplant. 2016 Sep;31(9):1437-43. doi: 10.1093/ndt/gfv448. Epub 2016 Jan 29.

43.

Early atherosclerosis aggravates renal microvascular loss and fibrosis in swine renal artery stenosis.

Sun D, Eirin A, Ebrahimi B, Textor SC, Lerman A, Lerman LO.

J Am Soc Hypertens. 2016 Apr;10(4):325-35. doi: 10.1016/j.jash.2016.01.019. Epub 2016 Jan 28.

44.

Differences in GFR and Tissue Oxygenation, and Interactions between Stenotic and Contralateral Kidneys in Unilateral Atherosclerotic Renovascular Disease.

Herrmann SM, Saad A, Eirin A, Woollard J, Tang H, McKusick MA, Misra S, Glockner JF, Lerman LO, Textor SC.

Clin J Am Soc Nephrol. 2016 Mar 7;11(3):458-69. doi: 10.2215/CJN.03620415. Epub 2016 Jan 19.

45.

Renal artery stenosis: if and when to intervene.

Textor SC, McKusick MM.

Curr Opin Nephrol Hypertens. 2016 Mar;25(2):144-51. doi: 10.1097/MNH.0000000000000202. Review.

46.

Hypercholesterolemia Impairs Nonstenotic Kidney Outcomes After Reversal of Experimental Renovascular Hypertension.

Sun D, Chen Z, Eirin A, Zhu XY, Lerman A, Textor SC, Lerman LO.

Am J Hypertens. 2016 Jul;29(7):853-9. doi: 10.1093/ajh/hpv222. Epub 2016 Jan 5.

47.

Blockade of CCR2 reduces macrophage influx and development of chronic renal damage in murine renovascular hypertension.

Kashyap S, Warner GM, Hartono SP, Boyilla R, Knudsen BE, Zubair AS, Lien K, Nath KA, Textor SC, Lerman LO, Grande JP.

Am J Physiol Renal Physiol. 2016 Mar 1;310(5):F372-84. doi: 10.1152/ajprenal.00131.2015. Epub 2015 Dec 9.

48.

Hypertension in 2015: Resistant hypertension: impact and evolving treatment options.

Lerman LO, Textor SC.

Nat Rev Nephrol. 2016 Feb;12(2):70-2. doi: 10.1038/nrneph.2015.199. Epub 2015 Dec 14. No abstract available.

49.

Chronic renal ischemia in humans: can cell therapy repair the kidney in occlusive renovascular disease?

Saad A, Herrmann SM, Textor SC.

Physiology (Bethesda). 2015 May;30(3):175-82. doi: 10.1152/physiol.00065.2013. Review.

50.

Paradigm Shifts in Atherosclerotic Renovascular Disease: Where Are We Now?

Textor SC, Lerman LO.

J Am Soc Nephrol. 2015 Sep;26(9):2074-80. doi: 10.1681/ASN.2014121274. Epub 2015 Apr 13. Review.

Supplemental Content

Loading ...
Support Center